EXPERT EXCHANGE: Management of Advanced EGFR Mutation-Positive NSCLC: Making Bold Strides Toward True Precision Medicine

The discovery of epidermal growth factor receptor gene (EGFR) mutations in non–small cell lung cancer (NSCLC) and the development of EGFR tyrosine kinase inhibitors (TKIs) have dramatically transformed the treatment landscape of EGFR...

 Read More